Advanced Cardiovascular Life Support Market Share, Rising Exponentially in the Forecast Period of 2032

Comments · 144 Views

Advanced cardiovascular life support (ACLS) are a set of equipment used for the prevention of stroke and other cardiovascular diseases.

Advanced cardiovascular life support (ACLS) are a set of equipment used for the prevention of stroke and other cardiovascular diseases. The global advanced cardiovascular life support market report by Market Research Future (MRFR) outlines pertinent trends and opportunities for players for the period of 2017 to 2023 (forecast period) in light of the rise in cardiovascular diseases.

The advanced cardiovascular life support market is anticipated to reach USD 9162.40 million by 2030, with an 8.80% CAGR over the forecast period 2022-2030.

The Advanced Cardiovascular Life Support (ACLS) market addresses the demand for specialized cardiac life support training and equipment. With cardiac emergencies being time-sensitive, ACLS training and interventions are crucial for healthcare professionals. The market offers innovative devices, simulation tools, and educational programs to enhance outcomes in cardiovascular emergencies, meeting the evolving needs of healthcare providers.

Market Scope

The global advanced cardiovascular life support market is predicted to expand at 7% CAGR during the forecast period. According to the World Health Organization (WHO), more than 35% of deaths in 2015 were caused by minor or major heart complications. Guidelines outlined by healthcare organizations for performing certain techniques after spontaneous circulation and post-resuscitation can work in favor of the market.

Large demand for emergency services and rising number of coronary and cardiovascular diseases can bode well for the global ACLS market. Excessive consumption of tobacco and alcohol, rising number of diabetics and obese, and continuous upgradation of equipment will work in favor of the market. But lack of trained personnel can hamper the market growth. Perioperative cardiac arrests occur in 4.3-7.5 out of 10,000 cases. Training programs for personnel can resuscitate persons and provide them a chance in the operating room. Supportive reimbursement policies, expansion of private hospitals in rural areas, and demand for critical care units can positively impact the market.


The global advanced cardiovascular life support market is segmented by techniques, algorithm, instruments, and end users.

By techniques, the market is segmented into electrical therapy, airway management, non-invasive airway, endotracheal intubation, and lethal arrhythmias. The airway management technique can account for a large market share owing to growing demand for emergency care and prevalence of chronic respiratory diseases.

By algorithm, it is segmented into suspected stroke algorithms, cardiac arrest, tachycardia, acute coronary syndromes, bradycardia, and others.

By instruments they are segmented into devices, accessories, and end users.

On the basis of end users, the market is segmented into cardiac catheterization labs, medical training centres, hospitals, and others. Hospitals can account for the majority of the market share owing to the use of ACLS equipment in operating rooms. Rising number of surgeries can warrant the need of devices for administration of oxygen and ventilation can fuel the segment growth.

Regional Analysis

The global advanced cardiovascular life support market market share covers growth opportunities across Americas, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).

The Americas are deemed to dominate the market till the end of the forecast period owing to the growing numbers of the elderly populace, well developed healthcare infrastructure, and high incidence of cardiovascular diseases. Interventions to increase survival after cardiac arrest as well as training of medical personnel to react rapidly can augur well for the market. The large healthcare spending in the U.S. and Canada is evident of the large potential for advanced cardiovascular life support devices. Moreover, insurance schemes covering coronary diseases will support this trend.

APAC is an emerging market for ACLS owing to change in lifestyles brought by urbanization, treatment and diagnosis of cardiovascular diseases, focus on its prevention, and a large patient pool. Lastly, the MEA can witness a spurt in demand for advanced cardiovascular life support equipment owing to the growing population and increase in healthcare spending by governments. According to the Health Education Department, the rise of incomes of patients in Africa will expand the healthcare spending and fuel market demand.

Competition Outlook

General Electric Company, Abbott, Asahi Kasei Corporation, CPR Medical Devices, Inc., Physio-Control, Inc., Michigan Instruments, Koninklijke Philips N.V., and Cardiac Science Corporation are key players of the global advanced cardiovascular support market.

For more information visit at MarketResearchFuture